Literature DB >> 16219951

Kawasaki disease in Hong Kong, 1994 to 2000.

Y M Ng1, R Y T Sung, L Y So, N C Fong, M H K Ho, Y W Cheng, S H Lee, W C Mak, D M L Wong, M C Yam, K L Kwok, W K Chiu.   

Abstract

OBJECTIVE: To describe the epidemiology, clinical characteristics, and management of Kawasaki disease in children in Hong Kong.
DESIGN: Retrospective survey of medical records from July 1994 to June 1997, and prospective data collection from July 1997 to June 2000.
SETTING: Hospitals with a paediatric unit in Hong Kong. PATIENTS: Patients diagnosed with Kawasaki disease between July 1994 and June 2000 in public hospitals in Hong Kong. MAIN OUTCOME MEASURES: Incidence of Kawasaki disease and coronary artery aneurysm rates.
RESULTS: A total of 696 cases of Kawasaki disease were reported. There were 435 (62.5%) boys and 261 (37.5%) girls giving a male to female ratio of 1.7:1. The age ranged from 1 month to 15 years 5 months with a median of 1.7 years. Infants (<1 year) constituted the largest group of patients (223, 32.0%) and overall, 638 (91.7%) were younger than 5 years. Skin rash, conjunctivitis, and oral signs were among the principal clinical features present in over 80% of cases. Prominent cervical lymph nodes larger than 1.5 cm were less commonly found (24%). Coronary artery aneurysms or ectasia were present in 15.7% (109/696), 8.5% (59/696), and 5.0% (35/696) of patients at 2, 4, and 8 weeks, respectively. The incidence of Kawasaki disease per 100,000 children under 5 years was significantly higher in the prospective study period than in the retrospective period (39 vs 26, P<0.001).
CONCLUSION: The incidence of Kawasaki disease is high in Hong Kong and is 39 per 100,000 children below 5 years of age. The coronary artery aneurysm prevalence is 5%. Intravenous gamma-globulin and high-dose aspirin is the mainstay of treatment.

Entities:  

Mesh:

Year:  2005        PMID: 16219951

Source DB:  PubMed          Journal:  Hong Kong Med J        ISSN: 1024-2708            Impact factor:   2.227


  17 in total

1.  Single-nucleotide polymorphism rs2290692 in the 3'UTR of ITPKC associated with susceptibility to Kawasaki disease in a Han Chinese population.

Authors:  Qian Peng; Changhui Chen; Yu Zhang; Hailan He; Qing Wu; Jing Liao; Bo Li; Caidan Luo; Xiaoping Hu; Zhi Zheng; Yuan Yang
Journal:  Pediatr Cardiol       Date:  2012-02-24       Impact factor: 1.655

2.  Epidemiologic survey of Kawasaki disease in Jilin from 1999 through 2008.

Authors:  Xiaomei Zhang; Zhen Zhang; Shicheng Liu; Jinghui Sun
Journal:  Pediatr Cardiol       Date:  2011-10-01       Impact factor: 1.655

Review 3.  Comparative effectiveness of intravenous immunoglobulin from different manufacturing processes on Kawasaki disease.

Authors:  Ming-Chih Lin
Journal:  World J Pediatr       Date:  2014-05-07       Impact factor: 2.764

4.  Epidemiologic survey of Kawasaki disease in Inner Mongolia, China, between 2001 and 2013.

Authors:  Xiaomei Zhang; Yanyan Liang; Wanyu Feng; Xuewen Su; Hua Zhu
Journal:  Exp Ther Med       Date:  2016-05-26       Impact factor: 2.447

5.  Coronary Artery Complications in Pediatric Patients with Kawasaki Disease: A 12-Year National Survey.

Authors:  Chun-Yen Chiang; Chung-Han Ho; Chin-Chen Chu; Zhih-Cherng Chen; Jhi-Joung Wang; Yung-Zu Tseng
Journal:  Acta Cardiol Sin       Date:  2013-07       Impact factor: 2.672

6.  Epidemiologic Study on Kawasaki Disease in Korea, 2007-2014: Based on Health Insurance Review & Assessment Service Claims.

Authors:  Sangmi Ha; Gi Hyeon Seo; Kyu Yeun Kim; Dong Soo Kim
Journal:  J Korean Med Sci       Date:  2016-09       Impact factor: 2.153

7.  Comparative effectiveness of intravenous immunoglobulin for children with Kawasaki disease: a nationwide cohort study.

Authors:  Ming-Chih Lin; Yun-Ching Fu; Sheng-Ling Jan; Mei-Shu Lai
Journal:  PLoS One       Date:  2013-05-01       Impact factor: 3.240

Review 8.  Epidemiology and management of Kawasaki disease.

Authors:  Nadia J C Luca; Rae S M Yeung
Journal:  Drugs       Date:  2012-05-28       Impact factor: 11.431

Review 9.  Epidemiology of Kawasaki disease in Asia, Europe, and the United States.

Authors:  Ritei Uehara; Ermias D Belay
Journal:  J Epidemiol       Date:  2012-02-04       Impact factor: 3.211

10.  Prediction of the risk of coronary arterial lesions in Kawasaki disease by serum 25-hydroxyvitamin D3.

Authors:  Yan-Li Chen; Juan-Li Wang; Wei-Qin Li
Journal:  Eur J Pediatr       Date:  2014-06-03       Impact factor: 3.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.